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stigma and discrimination, of their own reluctance to seek treatment, and 
of the unavailability of HIV/AIDS treatment in programmes for injecting 
drug users.
This guidance document, built on expert advice and developed in con-
sultation with UNAIDS, articulates the central principles for treatment 
and support of HIV-positive injecting drug users. It is addressed to policy 
makers, treatment planners and service providers, particularly those who 
deal with substance-dependent populations, and to patient organizations.  
It is intended not only to help ensure that this population has fair access to 
anti-retroviral and other HIV-related treatment— in line with that available 
to persons who are not substance-dependent—but to stimulate coordina-
tion and communication among healthcare providers in different delivery 
systems. Building on existing guidance documents for HIV prevention 
and treatment in a wide variety of settings, this document also describes 
components and concrete actions to promote these principles in prac-
tice. While the principles and implementing steps are interrelated and 
interdependent, in the interest of promoting a broad view of the unique 
problems posed by the group at hand, each principle is treated separately.
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5Principle 1
Human rights of drug dependent people with HIV/AIDS
The human rights of drug dependent people living with HIV/AIDS 
should be fully respected to ensure their appropriate treatment and 
psychosocial support.  They should not be subjected to stigma or 
discrimination because of their past or present drug use, health status 
including HIV/AIDS,  race, colour, sex, language, religion, political or 
other opinion, national or social origin, property, birth, physical or 
mental disability, sexual orientation or civil, political, social or other 
status. This principle forms the core of an ethical and effective strate-
gy for combating both drug dependence and the spread of HIV/AIDS.
Principle 2
Evidence-base for treatment, care and psychosocial support
The health and social care provided to drug dependent persons 
living with HIV/AIDS should be based on salient evidence. Evidence 
is essential for advocacy, planning and delivery of ‘good practice’ 
interventions.
Principle 3
Appropriate treatment and psychosocial support 
Drug dependent people living with HIV/AIDS should have access 
to appropriate and high quality services, which offer a full range of 
biological, psychological and social interventions, including drug 
dependence treatment, HIV/AIDS treatment and primary health care.  
These include detoxification and relapse prevention programmes, 
substitution maintenance therapy for opioid dependence, psycho-
social care, HIV testing and counselling, antiretroviral therapy, treat-
ment adherence support, post-exposure prophylaxis, treatment of 
opportunistic infections and co-infections as well as access to harm 
reduction interventions.
The Principles in Brief
6Principle 4
Equitable access to HIV/AIDS care and treatment including 
antiretroviral therapy (ART)
Past or present drug use should not pose a barrier to equitable access 
to all available state-of-the-art HIV/AIDS treatment and care, including 
anti-retroviral therapy and psychosocial support. Drug dependent 
people should be accorded the same treatment, care and psychosocial 
support as the rest of the HIV-positive population in their country, and 
their exclusion from such care is medically and ethically indefensible.
Principle 5
Supportive environments to enable and facilitate treatment, care 
and psychosocial support  
Restrictive policies that can impede access to effective treatment 
and care of individuals suffering from substance dependence and 
HIV/AIDS are detrimental both to the health and well-being of drug 
dependent people living with HIV/AIDS and to the larger community. 
Supportive environments will maximize the efficacy of the treatment 
and care such people receive by removing the obstacles that impede 
appropriate interventions and by creating the conditions, both 
national and local, that foster good practice and maximize the avail-
ability, acceptability and accessibility of treatment and care.
Principle 6
Client participation
Drug dependent people with HIV/AIDS should not be just passive 
recipients of treatment but should fully participate in the planning, 
delivery, evaluation and monitoring of services. 
Principle 7
Participation of community and other stakeholders
Community and non-government organizations should be active 
participants in, and advocates for, the development and implementa-
tion of treatment, care and psychosocial support for drug dependent 
people living with HIV/AIDS.
7 Drug dependent people are vulnerable to HIV/AIDS. Those who do 
not inject drugs risk contracting HIV from unsafe sexual behaviours 
while intoxicated or in exchange of sex for drugs or money. However, 
those who share injecting equipment, other drug use paraphernalia 
and drug solutions are at highest risk.  
Injection drug use (IDU) not only contributes significantly to the 
global HIV/AIDS epidemic but is itself a public health problem of 
enormous magnitude. IDU can result in serious health problems such 
as overdose, venous thrombosis and severe bacterial infections. In 
addition to HIV infection, sharing injection equipment carries a high 
risk of transmission of other blood-borne infectious diseases, such as 
hepatitis B, C and D, as well as exposure to additional strains of HIV, 
which can complicate treatment and impair its success. 
The spread of HIV among the estimated 13 million injecting drug 
users worldwide in 2005 creates a risk for this group and for other 
groups as well. From 5% to 10% of all new HIV infections are attribu-
table to injection drug use. The close inter-relationship between sex 
work and drug use in many countries creates a transmission bridge 
between drug-using and non-using populations. Significant propor-
tions of injecting drug users trade sex for drugs to support their drug 
dependence. As a result, HIV epidemics are being driven by injection 
drug use in a number of countries, notably in eastern Europe, Asia, the 
Middle East and south America.  
Despite the large numbers of drug dependent people living with HIV/
AIDS, there is considerable evidence that they do not enjoy equitable 
access to treatment and support services. Drug dependent people 
living with HIV/AIDS are stigmatized and discriminated against, 
resulting in their receiving inadequate services for both substance 
dependence and for HIV/AIDS. Individuals who report past or current 
injection drug use have less access to anti-retroviral medication and 
other HIV/AIDS treatment and care than others who are not sub-
stance-dependent. 
Introduction
8 Many drug dependent individuals are reluctant to seek any kind of 
treatment for a variety of reasons: 
• some do not wish to identify themselves as drug users because 
they fear  incarceration or being pressured to stop using drugs;
• some do not perceive themselves as “sick” and in need of treat-
ment or do not believe treatment would be effective; 
• some are not interested or willing to approach drug treatment 
agencies and programmes or to stop drug use; 
• some cannot afford the cost of treatment or the travel to reach 
services;
• some are discouraged from seeking help by the long waiting time 
to enter treatment in countries where the demand for treatment 
greatly exceeds treatment availability (particularly for agonist 
pharmacotherapy of opioid dependence).
 Furthermore, the availability of and access to drug treatment pro-
grammes vary greatly among and within countries, and a lack of coor-
dination and communication among healthcare providers in different 
delivery systems often results in fragmented utilization of services. As 
a result, many substance-dependent people do not receive adequate 
ongoing healthcare, and even those who enter drug treatment find 
difficulties in accessing general healthcare and social support services. 
For those drug dependent people living with HIV/AIDS, the situation 
is even more challenging. Differences in national healthcare and drug 
control policies and in financial and human resources contribute to a 
varied global landscape, but in general, the following scenarios pertain: 
• In developing and transitional countries, scarcity of financial and 
human resources necessitates prioritization of competing health 
needs. Drug dependent people living with HIV/AIDS face negative 
societal attitudes and stigma and discrimination by healthcare 
workers and decision-makers; they are thus rarely seen as a priority 
and have limited access to both drug-dependence and HIV/AIDS 
treatment. Serious barriers to treatment include: the prohibitive 
9cost of both drug dependence and HIV/AIDS treatment and care; 
poor geographical coverage of services; the misinformed notion 
that anti-retroviral treatments are unsuitable and inappropriate 
for drug users; and the legal and medical barriers to use all avail-
able effective  treatment options for drug dependence, as, for 
example, agonist maintenance therapy for opioid dependence. 
Furthermore, the public health infrastructure is inadequate in 
many countries, where physicians and other healthcare workers 
lack the training necessary to address substance use disorders 
and HIV/AIDS and the physical, psychological and social problems 
created and exacerbated by both conditions.
• In developed countries, access to HIV treatment by drug depen-
dent people is often limited by stigma and discrimination and by 
the lack of communication between the drug dependence and 
HIV/AIDS treatment systems. Many healthcare workers mistak-
enly believe that drug users must be drug-free before they can 
be treated for HIV disease.  Evidence of inequalities in access to 
HIV/AIDS treatment and care include discrimination because of 
drug use status past or present, legal status, gender, age, ethnicity, 
economic and social instability, as well as the lack of health insur-
ance coverage. 
•  In all countries in which drug dependent persons are incarcerated 
or confined to residential facilities (whether admitted on a volun-
tary or involuntary basis), their ability to access HIV/AIDS treatment 
depends on the availability of appropriate treatment programmes 
within, or in conjunction with, the facilities in which they reside.  
Unfortunately, such settings are often not integrated or linked with 
the community-based treatment programmes available to persons 
living with HIV/AIDS.
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Description and justification
 Drug dependent people living with HIV/AIDS should enjoy full human 
rights and not be subjected to stigma or discrimination because of 
their past or present drug use, HIV status, gender, sexual orientation, 
ethnicity, nationality, legal status, or social or economic circumstances.
Health and human rights complement and mutually reinforce each 
other, and both are critical for the success of treatment, care and sup-
port of all patients. Drug dependent people living with HIV are par-
ticularly vulnerable because they have two highly stigmatized condi-
tions. It is important to ensure that there are no legal impediments 
to effective treatment and psychosocial support for drug dependent 
people. Thus, drug dependent people should have the right to life, 
non-discrimination, and personal liberty, the right to the benefits of 
medical and scientific progress, the right to the highest attainable 
standard of physical and mental health, the right to an adequate 
standard of living and social security services, and the right to be free 
from cruel, inhumane or degrading treatment or punishment.
Components of this principle
1 Equality before the law.
2 Treatment with respect and dignity, including the confidentiality of 
personal information.
3 Elimination of prejudice, discrimination and stigma.
4 Equitable access to health and welfare services.
5 Access to information about treatment and care, the opportunity to 
participate in developing a treatment and care plan and to accept or 
decline particular interventions.
Principle 1
Human rights of drug dependent people 
with HIV/AIDS 
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Actions to promote this principle
1 Assess and analyze the human rights situation for drug dependent 
people living with HIV/AIDS. 
2 Perform high-level advocacy and awareness-raising to shape the 
nature of public debate.
3 Review criminal law, regulations and correctional system policies rele-
vant to treatment, care  and psychosocial support of drug dependent 
people living with HIV/AIDS, to ensure that they are consistent with 
international human rights standards. 
4 Enact or strengthen anti-discrimination and other laws that protect 
vulnerable groups such as drug users with HIV. 
5 Raise awareness of, and advocate for, changes in policies, legislation, 
regulations, positions or programmes that infringe the aforemen-
tioned human rights among policy makers, administrators, healthcare 
workers, and law enforcement personnel.
6 Develop concise, comprehensible and accurate information on 
human rights issues and the special needs of drug dependent 
people living with HIV/AIDS for key stakeholders (e.g. policy makers, 
administrators, healthcare workers, police, NGOs, community-based 
organizations), and provide this information to drug users living with 
HIV/AIDS. 
7 Review and assess services to determine whether stigmatization and 
discrimination occur. 
12
8 Develop appropriate and equitable treatment, care and support for 
drug dependent people living with HIV/AIDS through a process that 
includes client and community participation.
9 Support the development of a thriving civil society and in particular 
the establishment and/or strengthening of health service user groups 
and family groups.
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Description and justification
 The health and social care provided to drug dependent persons living 
with HIV/AIDS should be based on salient evidence.  Evidence is essen-
tial for the planning and delivery of ‘good practice’ interventions. Yet 
research evidence has not always been taken into consideration when 
interventions for substance-dependent people living with HIV/AIDS 
have been planned and implemented. A variety of interventions for 
drug dependence continue to be routinely offered despite evidence 
that they are ineffective (e.g. coerced detoxification in the absence 
of follow-up care). By contrast, some treatment options that provide 
demonstrable benefits for substance-dependent people are disal-
lowed in some countries (e.g. opioid substitution maintenance thera-
py). Likewise, the frequent exclusion of drug dependent people from 
HIV treatment or the insistence that they must be drug-free before 
anti-retroviral drugs are prescribed is not supported by research 
findings. To ensure good practice,  the collection, interpretation and 
integration of valid, significant and applicable patient-reported, 
clinician-observed and other research-derived evidence should be 
an important part of the treatment process. Lack of «conclusive» evi-
dence, based on rigorous research, on the effectiveness of a particular 
intervention should not preclude or delay the introduction of such an 
intervention if there is adequate evidence that such an intervention 
would be beneficial. The introduction of such «evidence-informed» 
interventions should be linked with the necessary operational 
research and evaluation elements that will help establish a stronger 
evidence-base. 
Principle 2
Evidence-base for treatment and 
psychosocial support  
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Components of this principle
1 Use of research evidence to ensure ‘good practice’ interventions for 
drug dependence.
2 Evaluation research and ongoing monitoring to obtain pertinent 
evidence. 
3 Continuous evaluation of evidence, and updating of practices.
4 Advocacy to inform policy-makers, health and welfare professionals, 
consumers and other stakeholders  about the evidence base for treat-
ment and psychosocial support for people with drug dependence 
and HIV/AIDS. 
Actions to promote this principle
1 Systematically review relevant research findings from world-wide 
research and analyze its applicability to the national/local situation.
2 Audit the services and resources that are available in the country/
community.
3 Systematically gather data on good practices using multiple methods.
4 Systematically involve clients and other stakeholders in reviewing this 
evidence. 
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5 Strengthen capacity of services to undertake operational research, 
monitoring and evaluation.
6 Assess training needs and develop appropriate training to ensure that 
data and research evidence are systematically disseminated.
7 Monitor and evaluate interventions and revise them in accordance 
with emerging evidence.
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Description and justification
 Drug dependence is a chronic, relapsing disorder, which may require 
long-term sustainable treatment and support, as does HIV. People 
who are drug dependent and living with HIV/AIDS should have 
access to appropriate and high-quality services, as do non-drug 
dependent patients, with a full range of biological, psychological and 
social interventions, including drug dependence treatment, HIV/AIDS 
treatment and care, and primary healthcare. Comprehensive services 
should include detoxification and relapse-prevention programmes, 
substitution maintenance therapy for opioid dependence, HIV tes-
ting and counselling, antiretroviral therapy, including post-exposure 
prophylaxis, treatment adherence support, treatment of opportunistic 
infections (particularly tuberculosis) and co-infections (notably hepa-
titis B and C and sexually transmitted infections), and harm reduction 
interventions.  
Drug dependence treatment for substance-dependent individuals 
with HIV/AIDS should occur concurrently with HIV/AIDS treatment 
and care, and all should be part of the general health care infrastruc-
ture with non-judgmental and unbiased staff. Failure to provide high 
quality treatment and psychosocial support can have far-reaching 
consequences for substance-dependent individuals, their families and 
their communities at large.
Treating drug dependence has consistently been shown to reduce 
the behaviours associated with HIV transmission, in addition to redu-
cing the innumerable associated medical and social harms. Tailored 
drug dependence treatment has also been proven effective at 
providing opportunities for early diagnosis of other health problems 
including HIV/AIDS, and the treatment of and counselling for these 
conditions--especially with regards to adherence to drug treatment 
regimens for other conditions. It is strongly recommended that 
programmes with a broad range of tools for combating substance 
dependence among injecting drug users be established in affected 
communities and be made available to as many users as possible. 
Principle 3
Appropriate treatment and 
psychosocial support 
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Components of this principle
1 Co-ordinated, geographically accessible, affordable, relevant, client 
centered, community-based and evidence-based drug treatment and 
HIV/AIDS services, scaled up in response to need. 
2 Services reflecting the heterogeneity of drug dependent people living 
with HIV/AIDS and tailored to the needs of women, minorities and 
other populations with special needs.
3 Treatment services that are comprehensive, multidisciplinary and 
linked with primary healthcare, community, sexual and reproductive 
health and other specialized services for associated illnesses such as 
tuberculosis (TB), hepatitis and sexually transmitted infections.
4 Treatment and rehabilitation services that enable people to (re)integrate 
into society (housing, employment, education schemes etc).
5 Services for people with drug dependence and HIV/AIDS are sustai-
nable based on the government resource commitments. 
6 Collaboration and partnerships between stakeholders and treatment 
providers ensure that services are complementary and mutually rein-
forcing, and available resources are put to best use.
7 Ongoing monitoring and evaluation of services. 
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Actions to promote this principle
1 Establish channels of communication among policymakers, health 
planners and service providers at both national and local levels to 
encourage joint planning and delivery of services. 
2 Develop partnerships and multi-sector collaboration among the 
healthcare system and other relevant sectors (welfare, housing, 
employment, criminal justice, etc.) to address the needs of drug 
dependent people with HIV/AIDS and help them to reintegrate into 
society. 
3 Establish comprehensive services that are part of the national 
response to substance dependence and to HIV/AIDS, to ensure that 
the systems of care are convergent, complementary, and  sustainable,  
and provide continuity of care.
4 Develop collaborative substance dependence and HIV/AIDS treat-
ment programmes where HIV can be diagnosed early in drug 
dependent persons so that timely interventions and follow-up treat-
ment and care are made available.
5 Develop sound medical and research infrastructure, which will train 
healthcare personnel, improve access and availability of treatment, 
ensure adequate supply of equipment and medication, and conduct 
evaluation research.
6 Develop diverse and comprehensive models of evidence-based care 
and psychosocial support for people with drug dependence and HIV/
AIDS, while ensuring that there is no gap between hospital and home 
care.  
7 Develop treatment and psychosocial support services in penal and other 
closed institutions for drug dependent people living with HIV/AIDS. 
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Description and justification
 Past or present drug use should not pose a barrier to equitable and 
universal access to all available state-of-the-art HIV/AIDS treatment 
and care including anti-retroviral therapy and psychosocial support. 
Exclusion is indefensible on ethical, human rights, and public health 
grounds, especially when a person is in a residential or custodial 
programme for drug dependent persons and is therefore not able to 
seek access to HIV treatment outside that programme. Drug depend-
ent people should be accorded the same treatment, care and psy-
chosocial support as the rest of the HIV-positive population in their 
country. 
Anti-retroviral treatment is an effective therapy which has been 
shown to be successful in arresting HIV progression and enabling 
those infected to achieve a satisfactory quality of life.  People with 
drug dependence are often excluded from ART on the grounds that 
their lifestyle and behaviours compromise the necessary strict adhe-
rence to these medications. However, successful models of care have 
demonstrated that people with drug dependence can overcome 
these difficulties and achieve results similar to non-drug users with 
regard to treatment adherence and delays in progression of HIV di-
sease. Therefore, they must not be excluded from ART on the ground 
of their drug dependence but afforded the same level of access as 
others in their community.
The ethics and human rights norms stipulated in Principle 1 mandate 
that no drug dependent person be excluded from ARV or any other 
effective treatment for HIV/AIDS based on presumptions about his or 
her expected adherence to the treatment regimen. 
Principle 4
Equitable access to HIV/AIDS care and 
treatment including antiretroviral therapy (ART)
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Components of this principle
1 Good quality treatment dictates that access to ART be available on an 
equitable basis to all suitable patients, including those with past or 
present drug use.
2 Not prescribing ART to people with drug dependence is a violation of 
human rights and ethical norms. 
3 Detoxification is not a necessary prerequisite to access and initiate 
HIV/AIDS treatment and care.
Actions to promote this principle 
1 Remove or repeal policies, restrictions and guidelines prohibiting ART 
for those with past or present history of drug dependence and those 
attending treatment programmes for drug dependence.
2 Research drug interactions which may inhibit adherence to treatment 
(e.g. between methadone, buprenorphine, other psychotropic drugs 
and antiretroviral medicines, and also between amphetamine-type 
stimulants, cocaine, alcohol and antiretroviral medicines). 
3 Develop treatment programmes and strategies to maximize adhe-
rence to ART, including for clients of residential or custodial treatment 
programmes.
4 Develop strategies to maximize client and broader community par-
ticipation in the planning and delivery of ART to people with drug 
dependence. 
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Description and justification
 Restrictive policies, legislation and regulations that can impede access 
to effective treatment of individuals suffering from drug dependence 
and HIV/AIDS are detrimental both to the health and well-being 
of drug dependent people living with HIV/AIDS and to the larger 
community. Supportive environments will maximize the efficacy of 
treatment, care and psychosocial support interventions. Supportive 
environments aim to remove obstacles that impede appropriate 
interventions and create the conditions, both national and local, that 
foster good practice and maximize the availability, acceptability and 
accessibility of treatment and care.  This approach is in line with the 
Ottawa Charter for Health Promotion, which advocates the creation of 
conditions conducive to implementing community-based interven-
tions and the adoption of policies supportive of public health.
Components of this principle
1 Policies, plans, programmes, regulations and laws conducive to quality 
treatment, care and support services for drug dependent people who 
are living with HIV/AIDS.
2 Interventions to ensure the reduction of discrimination, prejudice and 
marginalization. 
3 Advocacy for effective and feasible change.
4 Partnerships and collaboration between drug control, law enforce-
ment agencies, public health and social welfare institutions and 
organizations, and organizations of service users and their families.
5 Empowerment of clients and participation of stakeholders.
Principle 5
Supportive environments to enable and facili-
tate treatment, care and psychosocial support 
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Actions to promote this principle
1 Initiate dialogue with policy and decision-makers and regulators at 
national and local community level to ensure that there are no legal 
impediments to provision of treatment and support for drug depen-
dent people with HIV/AIDS.
2 Develop strategies to eliminate punitive and discriminatory approaches.
3 Develop training and education on drug dependence and HIV/AIDS 
for the judiciary and law enforcement agencies.
4 Train staff of social welfare services on drug dependence and HIV/AIDS.
5 Develop policy and organizational provisions to ensure equitable 
access to healthcare, employment, housing, education and social and 
financial services.
6 Establish the conditions to enable treatment and care programmes 
for incarcerated people with drug dependence and HIV/AIDS in pris-
ons and detention centres.
7 Establish training to ensure that stakeholders understand the chal-
lenges and are enabled to provide services that respect human rights, 
are efficient, effective, sympathetic to clients and confidential. 
8 Ensure that national plans are translated into local multi-sectoral col-
laboration to include the participation of patient families and peers, 
and community associations. 
9 Promote self-help and advocacy groups.
23
Description and justification
 People with drug dependence and HIV/AIDS should not be merely 
passive recipients of treatment, but fully participate in the planning, 
delivery, evaluation and monitoring of services. Client-centered 
interventions help to keep the focus on what patients want and need; 
those living with the conditions in question are knowledgeable about 
the needs of themselves and their peers, and can be effective in edu-
cating others on issues such as adherence to ART and potential drug 
interactions, as well as on strategies to overcome their difficulties. 
Moreover, participation in the administration and evaluation of one’s 
own healthcare is a fundamental and inalienable human right. 
Components of this principle
1 Using the skills and capacities of clients to participate in different 
areas including policy formulation, developing and determining 
appropriate treatment approaches and care delivery systems, and 
implementation of interventions.
2 Participation of drug dependent people living with HIV/AIDS in activi-
ties to document and analyze their needs. 
Principle 6
Client participation
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Actions to promote this principle
1 Foster dialogue between policymakers, treatment and care providers 
and clients.
2 Enable/encourage participation of clients in development of innova-
tive approaches to ensure human rights, supportive environments 
and access to high quality treatment and care including ART.
3 Develop appropriate strategies to disseminate and distribute materials 
on treatment, care and psychosocial support to reach target popula-
tion of drug dependent people living with HIV/AIDS.
4 Enable and encourage participation of clients in development of 
treatment plans for ART. 
5 Promote self-help and peer support organizations for advocacy, 
mutual support and encouragement, and exchange of information. 
6 Promote dialogue and links between clients and community 
organizations. 
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Description and justification
 Community organizations and nongovernmental organizations 
(NGOs) should be active participants in, and advocates for, the 
development and implementation of treatment, care and psycho-
social support for drug dependent people living with HIV/AIDS.
Involving the local community, including community leaders and 
opinion setters and local NGOs and other community-based organi-
zations, is crucial to developing, improving and managing treatment, 
care and psychosocial support for drug dependent people living with 
HIV/AIDS.  Doing so helps in the identification of local needs, addres-
sing issues of resource allocation, prioritizing and ensuring that scarce 
resources are put to best use. The participation of the community will 
also help overcome stigma and discrimination and will ensure appro-
priate responses to the needs of persons with drug dependence. 
Components of this principle
1 Responses and services that are locally available, geographically 
accessible, and sensitive to local needs.
2 Community education on drug dependence, HIV/AIDS and available 
treatment.
3 Community participation in implementation of hitherto unfamiliar 
treatment, care and psychosocial support approaches and changes in 
systems of care (e.g. ART, substitution maintenance therapy for opioid 
dependence, harm reduction programmes). 
4 Community participation in allocation of resources. 
5 Encouragement of communities to find their own solutions.
Principle 7
Participation of community and other 
stakeholders 
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Actions to promote this principle 
1 Establish regular forums for dialogue between community organiza-
tions and community leaders, NGOs and other organizations and 
institutions in the health, welfare and law enforcement sectors to 
determine resource allocation priorities. 
2 Partner with community organizations to eliminate discrimination, to 
advocate the removal of obstacles that hamper interventions, and to 
create conditions that promote quality treatment, care and psychoso-
cial support.
3 Train community stakeholders in the salient issues in treatment, care 
and psychosocial support of drug dependent people with HIV/AIDS. 
4 Develop and support community-based responses to HIV/AIDS 
associated with substance dependence (e.g. pharmacy-based 
programmes, drop-in centers run by NGOs, outreach activities, pro-
grammes administered by religious authorities).
5 Foster collaboration among diverse stakeholders, including those 
outside of the health sector, and maximize the role of NGOs and 
community-based organizations.
6 Establish community programmes to provide psychosocial support, 
assistance and home care to drug dependent people with HIV/AIDS 
and their families.
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 The principles presented in this document are aimed at significantly 
improving the availability and quality of care for drug dependent per-
sons living with HIV/AIDS. Treatment for both drug dependence and 
HIV/AIDS should be guided by these principles and integrated within 
a broadly based approach that includes prevention and psychosocial 
support. 
In order to ensure effective treatment and support for drug depend-
ent people living with HIV/AIDS it is recommended that these princi-
ples be followed in the development of policies and programmes.
Adherence to these principles will aid in the establishment of 
an effective national framework for responding to HIV/AIDS. It is 
important that this framework utilizes  a co-ordinated, participatory, 
transparent and accountable approach that  integrates HIV/AIDS and 
drug policy in programmes across all branches of government. Only 
through doing so can those responsible for treatment programmes 
and for governmental functions more broadly ensure that people 
with drug dependence and HIV/AIDS are receiving the treatment and 
care to which they are entitled.
Conclusion
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 This guidance document, built on expert advice and developed 
in consultation with UNAIDS, articulates the central principles 
for treatment and support of HIV-positive injecting drug users. 
It is addressed to policy makers, treatment planners, and 
service providers, particularly those who deal with substance-
dependent populations, and to patient organizations.
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